New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!

ANIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 22.60%

Insider Buying (Last 12 Months): $368,077.54

Insider Selling (Last 12 Months): $0.00

Anixa Biosciences Insider Trading History Chart

Anixa Biosciences Share Price & Price History

^$3.05

▼ -0.08 (-2.56%)

As of 11/20/2024 01:00 AM ET

Days: 30 | 90 | 365

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

From Crypto Swap Profits | Ad

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Anixa Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/30/2024	Lewis H. Titterton, Jr.	Director	Buy	21,646	$3.06	$66,236.76	890,754
7/26/2024	Arnold M. Baskies	Director	Buy	5,000	$3.09	$15,450.00	115,000
6/13/2024	Lewis H. Titterton, Jr.	Director	Buy	405	$2.70	$1,093.50	856,612
6/10/2024	Lewis H. Titterton, Jr.	Director	Buy	330	$2.60	$858.00	849,105
6/7/2024	Amit Kumar	CEO	Buy	25,000	$2.41	$60,250.00	516,925
6/7/2024	Lewis H. Titterton, Jr.	Director	Buy	10,738	$2.52	$27,059.76	848,775
6/7/2024	Michael Catelani	CFO	Buy	6,250	$2.40	$15,000.00	35,211
4/9/2024	Lewis H. Titterton, Jr.	Director	Buy	15,009	$3.28	$49,229.52	838,037
3/15/2024	Amit Kumar	CEO	Buy	30,000	$3.22	$96,600.00	491,925
3/15/2024	Arnold M. Baskies	Director	Buy	10,000	$3.63	$36,300.00	110,000
7/31/2023	Amit Kumar	CEO	Sell	11,800	$3.57	$42,126.00	461,925
7/20/2023	Michael Catelani	CFO	Buy	5,500	$3.64	$20,020.00	26,655
4/26/2022	Lewis H. Titterton, Jr.	Director	Buy	10,000	$2.79	$27,900.00	988,070
4/20/2022	Michael Catelani	President	Buy	2,509	$2.53	$6,347.77	12,635
1/11/2022	Lewis H. Titterton, Jr.	Director	Buy	2,000	$3.20	$6,400.00
1/7/2022	Amit Kumar	CEO	Buy	20,000	$3.00	$60,000.00
1/7/2022	Lewis H. Titterton, Jr.	Director	Buy	11,000	$3.08	$33,880.00

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Claim your FREE 2024 Gold Guide

SEC Filings (Institutional Ownership Changes) for Anixa Biosciences (NASDAQ:ANIX)

29.13% of Anixa Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Anixa Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/20/2024	Westside Investment Management Inc.	35,000	$0.11M	0.0%	+151.8%	0.109%
11/20/2024	Virtu Financial LLC	10,786	$34K	0.0%	N/A	0.034%
11/13/2024	D.A. Davidson & CO.	671,072	$2.11M	0.0%	-8.9%	2.085%
11/4/2024	Tyler Stone Wealth Management	42,016	$0.13M	0.0%	+100.0%	0.131%
10/22/2024	International Assets Investment Management LLC	37,800	$1.19M	0.0%	+170.0%	0.118%
8/12/2024	Concorde Asset Management LLC	13,969	$31K	0.0%	N/A	0.044%
8/9/2024	Dimensional Fund Advisors LP	17,544	$39K	0.0%	-17.2%	0.055%
7/29/2024	Nations Financial Group Inc. IA ADV	22,500	$50K	0.0%	+50.0%	0.070%
7/26/2024	Bank of New York Mellon Corp	73,050	$0.16M	0.0%	-16.1%	0.228%
5/20/2024	Virtu Financial LLC	16,156	$50K	0.0%	+47.2%	0.051%
5/6/2024	Staley Capital Advisers Inc.	10,000	$31K	0.0%	N/A	0.031%
4/24/2024	Simplicity Wealth LLC	13,969	$44K	0.0%	N/A	0.044%
1/24/2024	International Assets Investment Management LLC	54,320	$2.11M	0.0%	+274.6%	0.171%
11/9/2023	UBS Group AG	604,439	$1.98M	0.0%	-4.7%	1.945%
10/24/2023	Dakota Wealth Management	15,000	$49K	0.0%	N/A	0.048%
10/24/2023	Mission Wealth Management LP	501,168	$1.64M	0.1%	N/A	1.613%
7/25/2023	Concorde Asset Management LLC	15,481	$50K	0.0%	N/A	0.050%
7/14/2023	Westside Investment Management Inc.	13,800	$44K	0.0%	N/A	0.045%
5/1/2023	Virtu Financial LLC	18,409	$79K	0.0%	N/A	0.060%
4/27/2023	Simplicity Solutions LLC	15,481	$67K	0.0%	N/A	0.050%
4/19/2023	International Assets Investment Management LLC	14,500	$62K	0.0%	+31.8%	0.047%
2/8/2023	Cambridge Investment Research Advisors Inc.	40,100	$0.17M	0.0%	+167.3%	0.130%
2/7/2023	Nations Financial Group Inc. IA ADV	13,000	$55K	0.0%	N/A	0.042%
1/30/2023	International Assets Investment Management LLC	11,000	$47K	0.0%	N/A	0.036%
11/10/2022	UBS Group AG	621,691	$3.06M	0.0%	+2.7%	2.028%
10/25/2022	Raymond James & Associates	60,846	$0.30M	0.0%	-7.1%	0.198%
10/17/2022	Cambridge Investment Research Advisors Inc.	15,000	$74K	0.0%	N/A	0.049%
7/22/2022	Gemmer Asset Management LLC	35,000	$0.11M	0.0%	N/A	0.115%
4/28/2022	Keybank National Association OH	15,510	$42K	0.0%	N/A	0.051%
2/22/2022	Tyler Stone Wealth Management	21,008	$62K	0.0%	N/A	0.070%
2/14/2022	Long Focus Capital Management LLC	21,297	$63K	0.0%	N/A	0.071%
2/10/2022	B. Riley Wealth Management Inc.	17,000	$50K	0.0%	+41.7%	0.056%
2/8/2022	Raymond James & Associates	56,902	$0.17M	0.0%	+10.4%	0.189%
11/16/2021	Adirondack Trust Co.	7,000	$33K	0.0%	N/A	0.023%
11/15/2021	Marshall Wace LLP	41,973	$0.20M	0.0%	N/A	0.140%
11/12/2021	Renaissance Technologies LLC	212,200	$1.01M	0.0%	+70.4%	0.709%
11/12/2021	Geode Capital Management LLC	263,951	$1.26M	0.0%	+23.5%	0.881%
11/9/2021	BlackRock Inc.	110,292	$0.53M	0.0%	-6.6%	0.368%
11/2/2021	Raymond James & Associates	51,550	$0.25M	0.0%	-4.6%	0.172%
11/1/2021	Cedar Brook Financial Partners LLC	10,000	$48K	0.0%	N/A	0.033%
10/22/2021	Spire Wealth Management	14,500	$69K	0.0%	-17.1%	0.048%
10/8/2021	Wealth Alliance Advisory Group LLC	16,413	$78K	0.0%	N/A	0.055%
8/16/2021	State Street Corp	23,287	$90K	0.0%	N/A	0.078%
8/13/2021	Renaissance Technologies LLC	124,499	$0.48M	0.0%	N/A	0.416%
8/13/2021	Northern Trust Corp	61,282	$0.24M	0.0%	+24.8%	0.205%
8/13/2021	Geode Capital Management LLC	213,804	$0.83M	0.0%	+26.5%	0.714%
8/13/2021	Vanguard Group Inc.	1,302,231	$5.05M	0.0%	+1.7%	4.348%
8/11/2021	Bank of New York Mellon Corp	43,302	$0.17M	0.0%	-15.0%	0.145%
5/21/2021	Citadel Advisors LLC	19,682	$92K	0.0%	+35.8%	0.063%
5/18/2021	Citadel Advisors LLC	19,682	$92K	0.0%	+35.8%	0.063%
5/18/2021	Jane Street Group LLC	26,093	$0.12M	0.0%	N/A	0.083%
5/14/2021	First Manhattan Co.	6,500	$30K	0.0%	N/A	0.021%
5/14/2021	Stifel Financial Corp	20,000	$94K	0.0%	N/A	0.064%
5/13/2021	Barclays PLC	9,998	$47K	0.0%	N/A	0.032%
5/12/2021	Geode Capital Management LLC	168,958	$0.79M	0.0%	+51.1%	0.538%
5/12/2021	UBS Group AG	587,481	$2.75M	0.0%	-5.0%	1.869%
5/7/2021	BlackRock Inc.	102,220	$0.48M	0.0%	+8.8%	0.325%
4/28/2021	Wealth Alliance Advisory Group LLC	20,100	$94K	0.0%	N/A	0.064%
4/27/2021	Dorsey Wright & Associates	8,093	$38K	0.4%	N/A	0.026%
4/27/2021	Concorde Asset Management LLC	13,000	$61K	0.0%	N/A	0.041%
2/11/2021	B. Riley Wealth Management Inc.	12,000	$37K	0.0%	N/A	0.046%
2/11/2021	Northern Trust Corp	49,291	$0.15M	0.0%	-5.2%	0.189%
2/9/2021	Bank of New York Mellon Corp	51,969	$0.16M	0.0%	+32.0%	0.199%
2/5/2021	BlackRock Inc.	93,942	$0.29M	0.0%	+8.0%	0.360%
11/17/2020	Jane Street Group LLC	18,495	$45K	0.0%	N/A	0.078%
11/13/2020	Morgan Stanley	14,484	$35K	0.0%	-43.1%	0.061%

Data available starting January 2016

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Today's Range

Now: $3.05

$3.02

$3.19

50 Day Range

MA: $3.26

$2.99

$3.97

52 Week Range

Now: $3.05

$2.14

$5.13

Volume

31,056 shs

Average Volume

108,905 shs

Market Capitalization

$97.99 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Who are the company insiders with the largest holdings of Anixa Biosciences?: Anixa Biosciences' top insider investors include:
Lewis H Titterton Jr (Director)
Amit Kumar (CEO)
Arnold M Baskies (Director)
Michael Catelani (CFO)
Learn More about top insider investors at Anixa Biosciences.
Who are the major institutional investors of Anixa Biosciences?: Anixa Biosciences' top institutional shareholders include:
D.A. Davidson & CO. — 2.09%
Tyler Stone Wealth Management — 0.13%
International Assets Investment Management LLC — 0.12%
Westside Investment Management Inc. — 0.11%
Virtu Financial LLC — 0.03%
Learn More about top institutional investors of Anixa Biosciences stock.
Which major investors are selling Anixa Biosciences stock?: During the last quarter, ANIX stock was sold by these institutional investors:
D.A. Davidson & CO.
Which major investors are buying Anixa Biosciences stock?: In the previous quarter, ANIX stock was acquired by institutional investors including:
International Assets Investment Management LLC
Westside Investment Management Inc.
Tyler Stone Wealth Management
Virtu Financial LLC
In the last year, these company insiders have bought Anixa Biosciences stock:
Lewis H Titterton Jr (Director)
Amit Kumar (CEO)
Arnold M Baskies (Director)
Michael Catelani (CFO)
Learn More investors buying Anixa Biosciences stock.